U.S. House — NV-04
H2NV04011When the regulator and the regulated share the same donors, you deserve to know.
Less than $1 / week · Cancel anytime
Voting records are public. Most people never look. Now you can.
Less than $1 / week · Cancel anytime
Some members of Congress made millions trading on what they knew. This shows you if yours did.
Less than $1 / week · Cancel anytime
The donors already know what they expect. Shouldn't you?
Less than $1 / week · Cancel anytime
Most voters never see this list. Now you can.
Less than $1 / week · Cancel anytime
See exactly who — and what they're spending to get in return.
Less than $1 / week · Cancel anytime
Every figure here traces to public government filings. Those records are filed as ranges, updated on a lag, and spread across sources that were never built to be searched together — so totals are close estimates, not exact to the dollar or the trade. We work continuously to surface the truest, most complete picture available on each candidate.
This member sits on committees that regulate the same industries funding their campaign — the money in, the power they hold, and their record on that sector, side by side. Each figure traces to its public source. You decide.
Sits on: House Committee on Ways and Means — Health
This committee sets rules for drug pricing, pharmaceutical approvals, and prescription drug access — the committee big pharma spends the most to influence.
Sits on: House Committee on Ways and Means
This committee controls federal tax policy, spending bills, and financial regulations — the committee with the broadest impact on corporate profits.
See exactly who paid — and how they voted on it
Unlock the named donors behind each conflict and this member’s votes and bills on their issues.
Based on FEC disclosures, STOCK Act filings & congressional record · Nonpartisan
No direct donor data yet
Mostly individuals
16% outside/Super PAC money (Dark Money Potential)
$4.4M in outside spending
No committee/donor overlaps
Clean
Trade data not yet available
Check FEC.gov
40 recorded votes · 5 bills sponsored
40 votes
This measures what share of direct campaign donations came from corporations and PACs versus individual citizens. Higher corporate concentration means special interests have more access — and more leverage.
Independent expenditures (Super PAC spending) don't appear in a candidate's own fundraising, but are still spent to elect them. Super PACs disclose their donors — but that money often originates from 501(c)(4) ‘dark money’ nonprofits that never have to reveal their original funders, so the true source can stay hidden. A high share here means more of the campaign is bankrolled by outside groups, with real potential for undisclosed money behind them. Confirmed dark-money vectors are flagged separately below.
A conflict of interest exists when a lawmaker sits on a committee that regulates the same industry that funds their campaign. When the regulator and the regulated are financially connected, voters should ask: whose interests come first?
STOCK Act trading disclosures are required by law but our data feed for this member is still being indexed. Check the full record directly at FEC.gov or congress.gov financial disclosures.
This shows recent voting participation and legislation introduced. Members who skip votes or introduce few bills may be less engaged with their legislative duties — or may be spending more time fundraising.